Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes

Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes

Abstract Background Anti-factor Xa assays and activated partial thromboplastin time (aPTT) are mainly employed to monitor patients treated with heparins. According to the Clinical and Laboratory Standards Institute and the French Working Group on Haemostasis and Thrombosis, anti-factor Xa activity a...

Full description

Bibliographic Details
Main Authors: Marion Gremillet, Laurie Talon, Aurélien Lebreton, Thomas Sinegre
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Thrombosis Journal
Subjects:
Blood coagulation tests
Drug monitoring
Heparin
Haemostasis
Pre-analytical phase
Online Access:https://doi.org/10.1186/s12959-023-00465-8

Internet

https://doi.org/10.1186/s12959-023-00465-8

Similar Items